Pfizer Inc. (NYSE:PFE) is included among the Dividend Champions, Contenders, and Challengers List: 15 Highest Yielding Stocks ...

Historical patterns indicate that abrupt fluctuations in the market can impact any firm, regardless of its seeming dominance.

NEW YORK, Feb 10 (Reuters) - Pfizer ‌agreed ​to accept $29 million to ‌resolve a dispute with the U.S. Securities and Exchange ​Commission stemming from the regulator's 2013 insider trading settlement ...

The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far.

The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far ...

The S&P 500 was on track for double-digit earnings growth, with more than half of companies having reported Q4 results so far ...

Eli Lilly rated SELL: rich valuation priced for perfection, rising GLP-1 competition, pricing pressure, and patent-cliff risk. Click here to read more on LLY stock.

The pipeline remains critical in determining Pfizer’s ability to pull itself out of a declining top line, but the $4.4 ...

Pfizer shares are down despite exceeding earnings expectations, primarily due to concerns over modest 2026 guidance and ...

Pfizer on Tuesday hailed a study of a weight-loss-drug candidate while forecasting a profit decline due to the impact of the ...

At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.